Defunct Company
Total Trials
9
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,237
NCT03131700
Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2017
Completion: Jan 31, 2018
NCT03584893
The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey
Phase: N/A
Start: Jun 1, 2018
Completion: Mar 1, 2023
NCT05300334
Investigation of ADA Enzyme Deficiency
Start: Oct 10, 2019
Completion: Oct 10, 2022
NCT04113083
An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease
Start: Oct 19, 2019
Completion: Jun 10, 2022
NCT04218006
A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)
Start: Dec 1, 2019
Completion: Mar 31, 2022
NCT05300347
Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA)
Start: Jun 17, 2021
Completion: Jun 17, 2023
NCT05300360
Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Proteinosis
Start: Aug 16, 2021
Completion: Aug 16, 2022
NCT05300373
Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E
Start: Dec 3, 2021
Completion: Dec 3, 2023